%A Guo Tianhui, Wang Haoming, Ren Ruimei, Xu Jinpeng, Song Hao, Xiao Wenjing, Xu Mingjin, Liu Xiguang %T Progress of radiomics and radiogenomics in lung cancer %0 Journal Article %D 2018 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2018.09.012 %P 566-569 %V 45 %N 8 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10519.shtml} %8 2018-09-08 %X Radiomics and radiogenomics are used to provide comprehensive tumor biological characteristics and further clinical information by extracting, screening and analyzing the most valuable quantitative radiomics features. In recent years, numerous studies have shown that radiomics plays a role in the diagnosis, treatment and predicting efficacy and prognosis of lung cancer. Radiogenomics shows a great value in the prediction of lung cancer gene phenotype and individualized precision treatment by combining radiomics features with genomics, proteomics and so on. Radiomics and radiogenomics are noninvasive, quantitative, and reproducible, and they can provide multidirectional tumor biological characteristics, which are expected to be widely used in the precise medical treatment of lung cancer in the future.